The major health complication of overweight and obesity is cardiovascular disease (CVD). Although dietary fat is often seen as major cause of obesity, there is no strong evidence that decreasing the dietary fat content as such, without actively improving energy balance, prevents weight gain. The limited and heterogeneous data from long-term randomized trials suggest that a 10% of energy higher fat intake results in equal or at the very most 3 kg larger body weights as compared with higher carbohydrate intake. The consequence of some possible weight gain for CVD risk should be balanced against effects of diet composition independent of body weight. There is strong and consistent evidence from metabolic and clinical studies that under isoenergetic conditions, diets high in unsaturated fat are more effective for reducing CVD risk than low-fat diets. A quantitative estimation of effects on risk factors indicates that even if increasing unsaturated fat intake at the expense of carbohydrates would produce some weight gain on the long-term, the net effect on CVD risk is probably beneficial.
Introduction
Overweight and obesity are the most pressing public health problem in modern societies. The major ultimate complication with increased body weight is cardiovascular disease (CVD), mediated through a set of mechanisms and risk factors often denoted as the metabolic syndrome. The composition of the diet may be of relevance for effective weight loss and prevention of weight gain, but it can also substantially affect CVD risk independent of body weight. For choosing the optimal diet for weight control and weight loss, not only effects on body weight itself, but in particular effects on health outcome should be considered.
Fat, carbohydrate and body weight
Several systematic reviews have combined studies in which the fat/carbohydrate ratio of the diet was modified [1] [2] [3] [4] [5] [6] [7] ( Table 1) . These found average effects on body weight that ranged from some 3 kg weight gain to 3 kg weight loss. Most, but not all included studies in these reviews were intended for weight loss in overweight subjects. A major problem in these studies is that intervention and control groups are very difficult to blind, and that fat reduction groups often received different intensity of instructions and other measures to enhance weight loss. Also, included studies were highly heterogeneous in terms of duration, design, degree of obesity of subjects, intensity of intervention, aimed and achieved energy-restriction and in dietary components other than fat. Thus, interpretation of results is difficult. Nevertheless, these systematic reviews indicate that weight loss over longer periods is not substantial. Table 1 also suggests that the outcomes of the various reviews are dependent on what type of diet is chosen as the 'active' treatment, that is, studies with focus on low fat slightly favouring low-fat treatment, and studies with focus on low carbohydrates slightly favouring low-carbohydrate treatment. Regardless, without taking the strengths and weaknesses of the different reviews into account, the effect of reducing fat intake is, if anything, at most some 3 kg weight loss, and not 3-5 kg as Astrup states. On the other hand, the evidence also does not support that a reduction of carbohydrate intake will lead to sustained weight loss. In one review of low-carbohydrate diets, 2 weight loss was associated with a lower energy intake, but not with a lower carbohydrate content of the diet. Body weight was on average 2.1-3.6 kg, but not significantly, lower on low-carbohydrate diets in the included trials with a controlled design. 2 From a recent systematic review of five randomized trials, it can be concluded that low-carbohydrate, non-energy-restricted diets are over 1 year not more effective than low-fat, energy restricted diets in inducing weight loss. 4 I support the notion by Astrup and many others that compliance to energy restriction is key for the effectiveness of long-term weight management. In the meta-analysis of Pirozzo et al.
5 (Table 1) , included studies had no sustained intervention beyond 6 months, except for one. 8 In this trial of moderate vs low-fat diets in 101 overweight men and women, active intervention was maintained for a period of up to 18 months. In subjects who kept participating in the dietary programme, weight loss after 12 months was 5 kg in both groups, whereas after 18 months subjects on the low-fat diet regained some 2 kg weight. Based on an intention-totreat analysis, however, the differences were much larger. After 18 months, subjects assigned at baseline to the moderate fat group had a 4 kg lower body weight, whereas those assigned to the low-fat group gained 3 kg of weight. This striking difference of 7 kg is explained by the much higher number of people that remained compliant to the moderate fat diet, which was apparently more palatable and easier to adhere than the low-fat diet. 8 In a large trial comparing four popular diets with large differences in fat, carbohydrates and protein (Atkins, Ornish, Weight Watchers, Zone), the adherence level as reported by the participants themselves rather than the composition of the diets determined the amount of weight loss. 9 The large WHI trial recently reported that a low-fat dietary pattern over 7.5 years did not lower body weight. 10 As Astrup notes, a secondary analysis showed that the reduction in percentage of energy from fat in both groups was associated with more weight loss. However, the difference was only 1.5-2 kg in women reporting 411% of energy reduction in fat. It is plausible that this group reflects women with a more conscious lifestyle and adherence to guidelines, which can help prevent weight gain. Thus, both low-fat and higher fat diets can be effective for weight loss, but success mainly depends on compliance to energy restriction. Similarly, there is consensus that an effect of diet on preventing weight gain in the population would be through a sustained lower energy intake. Lowering fat intake might help to reduce excessive energy consumption through effects on fuel metabolism and less feelings of hunger, but it is not established how this translates to body weight on the long-term. High-fat foods are often energy dense and this can lead to increased energy intake through a lower satiety-inducing effect. However, there are many energy-dense foods that facilitate excess energy intake. Modern low-fat 'light' products are often equal or only slightly lower in energy density as their full-fat counterparts, and with high-carbohydrate soft drinks it is easy to ingest a large amount of energy. These issues are discussed in more depth by others in this workshop.
Taken together, there is no strong evidence that lowering dietary fat as such, without intentionally reducing energy intake, will in the long-term lead to important weight loss or prevent weight (re)gain in the population. For weight loss, compliance to diets -that is, maintaining energy restriction -is key. A reduction in fat could be one measure to facilitate lower energy intake, but effects on energy density should be seen in the light of the whole diet and be balanced against ultimate health benefits.
Type of fat and CVD risk
The type of fat has no effect on energy balance, because saturated, trans, and cis unsaturated fatty acids are all almost completely absorbed and provide equal amounts of energy when metabolized. Although there have been a few studies suggesting differences in satiating effects of different fat sources, the effects are at best small. Nonetheless, the type of fat can have substantial effects on CVD risk. Lowering the amount of saturated and trans fatty acids is primary, but when considering how much total fat and carbohydrates a healthy diet should contain for weight control, a relevant question is how unsaturated fatty acids affect CVD risk as compared to carbohydrates. Blood lipid levels are the most established coronary heart disease (CHD) risk factors, and there is a wealth of data from well-controlled feeding studies on how these are affected by the dietary amounts of carbohydrate and different fatty acids. 11 These data show that saturated and trans fatty acids strongly raise total and low-density lipoprotein (LDL) cholesterol, whereas cis monounsaturated and polyunsaturated fatty acids lower it. All types of fat raise high-density lipoprotein (HDL) cholesterol by about 0.01 mmol/l per 1% of energy when they replace carbohydrates, except for trans fatty acids, which have the same effect as carbohydrates. Effects on triglycerides are opposite to HDL cholesterol. All types of fatty acids, except trans fatty acids, lower fasting triglyceride levels relative to carbohydrates by about 0.02 mmol/l per 1% of energy. The total/HDL ratio is the most powerful blood lipid predictor of CHD risk. 12, 13 As compared to carbohydrates, saturated fatty acids have a small increasing effect, trans fatty acids are clearly adverse, whereas monounsaturated and polyunsaturated fatty acids lower the total/HDL cholesterol ratio 11 ( Figure 1 ).
The direction of these effects are in line with a large prospective epidemiological analysis of dietary fatty acids, carbohydrates and risk of CHD 14 in 80 000 women over 14 years of follow-up. As compared with 5% of energy as carbohydrates, 5% as saturated fatty acids was associated with a 17% higher risk of CHD, whereas 5% of energy as nonhydrogenated polyunsaturated fats and monounsaturated fat were associated with decreased risks of 34 and 18%, respectively. Trans fatty acids were associated with a very large increase in risk. Total fat intake was not significantly related to risk, probably because of the opposing effects of different fat types.
The strongest type of evidence comes from long-term randomized trials on CHD end points. A few trials specifically tested the effects of changing dietary fat intake for periods of more than 2 years, without involving other treatments, such as blood pressure or plasma lipid lowering medication, or combined lifestyle and diet combinations. 15 Only two clinical trials tested the effect on CHD end points of a low-fat, high-carbohydrate diet to replace saturated fat. Neither of these low-fat trials showed significant benefits. In four other trials, saturated fat intake was reduced by prescribing unhydrogenated soybean oil and other vegetable oils to hypercholesterolemic patients, and thus tested the effect on CHD end points of a high-polyunsaturated fat diet. In all these trials, CHD incidence as well as cholesterol was substantially lowered. 15 The recent WHI trial also found no benefits for CVD of reducing total fat intake. 16 There is an issue with compliance in this trial as mentioned above, but it is likely the intervention was not effective because it reduced intakes of both saturated and trans fatty acids, and those of protective polyunsaturated and monounsaturated fatty acids. Thus, evidence from metabolic studies, epidemiological observations and clinical trials together provide strong and consistent evidence that (poly)unsaturated fatty acids are more effective for reducing CVD risk than carbohydrates. Earlier suggested adverse effects of higher fat diets on cancer are not substantiated by human studies. 17 Many current dietary recommendations for preventing CVD risk are for good reasons liberal as to total fat intake, but rather focus on reducing saturated and trans fatty acid intake.
Effects of weight loss vs those of unsaturated fatty acids on CVD risk factors
If a high-unsaturated fat diet would increase body weight as compared with a lower fat, carbohydrate-rich diet -as Astrup states -then how would the adverse effect on CVD risk resulting from this weight gain compare to the beneficial effects of unsaturated fatty acids independent of the weight gain? For a theoretical comparison, let us assume that raising total dietary fat content from 28 to 38%, by isoenergetic substitution of 7% monounsaturated and 3% polyunsaturated fatty acids for carbohydrate, would raise body weight by as much as 3 kg. From controlled clinical studies, 7, 18, 19 it can be estimated that each 1 kg weight loss will lower total cholesterol by about 0.03 mmol/l, lower fasting triglycerides by 0.015-0.035 mmol/l, and raise HDL cholesterol by 0.01 mmol/l. This is in line with observational data. 20 For 3 kg weight difference, we multiply these estimates by 3. The effects on blood lipids of the 10% increase in unsaturated fat intake independent of weight can be predicted from controlled studies under isoenergetic conditions. 11 Table 2 shows that the predicted favourable effects on blood lipids owing to increasing unsaturated fatty acids intake would outweigh an adverse effects of the supposed 3 kg weight gain. Changes in body weight might also affect CVD risk through other mechanisms, such as blood pressure, inflammation and insulin sensitivity. It can be estimated that a 3 kg increase in body weight would increase blood pressure by about 3 mm Hg, 23 but according to the recent OmniHeart trial, 24 a 10% increase in monounsaturated fatty acids as compared to carbohydrates would also lower blood pressure by 1.5-3 mm Hg pressure (depending on the degree of hypertension) ( Table 2 ). The effects on insulin sensitivity and inflammation are harder to quantify, but the independent predictive value of these factors for CVD risk is less established than for blood lipids and blood pressure. Of course, obesity may also result in health problems other than CVD, such as ostheoarthritis and diabetes resulting from overweight is an important disease in itself. Multiple lifestyle interventions have indeed shown large reductions in risk of diabetes, 25, 26 but these cannot be ascribed to weight loss only. Also, it is conceivable that beneficial effects of highunsaturated fat diets on glucose metabolism 27 may oppose an adverse effect of some weight gain on insulin sensitivity. Based on the predicted changes in the total/HDL cholesterol ratio, a loss of 3 kg body weight would lower risk by some 5-10%, 12, 13 whereas an increase of 10% of energy in unsaturated fat intake would lower it by 7.5-15% (Table 2) . For blood pressure, however, weight loss seems slightly favourable. It must be noted that the predictions of fatty acid effects on blood cholesterol mainly derive from studies in normal weight people, 11 and that effects in obese people may be somewhat smaller. 28 On the other hand, the effects on triglycerides, which predict CVD risk independent of total and HDL cholesterol, 21 are clearly more favourable for the high-unsaturated fat diet than for the lower fat diet. Of course, this theoretical example has several uncertainties. Nevertheless, it suggests that beneficial effects of increasing unsaturated fatty acid intake at the expense of carbohydrates would probably outweigh adverse effects through a modest, long-term increase on body weight, if any.
Type of carbohydrates
There is much less clear evidence on the health effects of different types of carbohydrates than there is on different types of fat. The reason is that carbohydrates not only occur in the diet in different forms, but that in addition their digestibility and metabolic effects seem dependent on the type and processing of the foods, and meal composition, size and frequency. Thus, it is hard to separate effects of a specific type of carbohydrates from those of the foods and other meal constituents by which it is delivered.
The type of carbohydrates does not seem to have a major effect on blood lipids, but there are notable exceptions. The soluble fibre beta-glucan has a modest, but established effect on total and LDL cholesterol. 29, 30 Fructose is differently metabolized than glucose, and may therefore increase triglycerides, in particular in the postprandial state, and perhaps also LDL cholesterol. 31 Different qualities of carbohydrates that have been related to CVD risk are the glyceamic index, the dietary fibre content and the degree of processing (whole vs refined) of grains. Several, but not all, observational studies found a higher risk of CHD 32, 33 and diabetes 34 with a higher glyceamic index or load. However, residual confounding by overall poor diet quality cannot be ruled out, and controlled long-term trials on CHD outcome with glyceamic index or load as the sole variable are lacking. Observational studies consistently show an inverse relation between CVD risk and fibre intake, in particular from cereal sources. 35 Although there is no evidence from long-term randomized controlled trials to support this, and the responsible dietary factors are unclear, the available evidence indicates that including highfibre or whole-grain foods in the diet might help to reduce CHD risk. The effects of carbohydrates are dealt with in more detail elsewhere in this workshop.
Role of protein
Recently, the scientific interest in the role of protein in weight control has increased considerably, partly triggered by the popular Atkins and Zone diets. Several studies support that a high-protein diet as compared with a high-carbohydrate diet promotes weight loss, 36,37 but others do not. 38, 39 An effect of protein could be due to a more satiating effect, along with a slightly higher postprandial thermogenic response. The recent study by Weigle et al. 40 that Astrup quotes suggests a sustained decrease in ad libitum energy intake with increased protein intake as compared with fat, The difference in effect on blood pressure would predict about 0-5% lower CVD risk in favour of weight loss. 22 and an impressive weight loss over 12 weeks. However, this study lacked a concurrent control group. Overall, there is some evidence that high-protein diets in the shorter term (6 months) enhance weight loss under ad libitum conditions, but long-term data are lacking. As with fat vs carbohydrates, the difference in efficacy under isoenergetic conditions and success of compliance should be elucidated.
What is the evidence that increasing dietary protein hasunder isoenergetic conditions -advantages for CVD risk? Compared to fat and carbohydrates, there are only a few controlled feeding studies on protein and blood lipids at constant body weight. Katan 41 summarized four such studies, and found that an increase of 13 en% in protein intake on average lowered the total/HDL cholesterol ratio by 0.20.as compared with carbohydrates. This favourable effect is about half that of unsaturated fatty acids 11 ( Figure 1 ). In addition, proteins seem -like fat -to lower fasting triglycerides as compared with carbohydrates. 38 Epidemiological studies found lower CHD risks with higher protein diets, in particular with protein from vegetable source, 42 and also suggest a lower risk of hypertension with high-protein intake. 38 In the recent OmniHeart trial, a high-protein diet lowered blood pressure by 1.5-3 mm Hg (depending on the degree of hypertension) relative to carbohydrates. 24 The DASH study showed that a dietary pattern combining protein from low-fat dairy with fruits and vegetables lowers blood pressure. 43 From the DASH trial, however, it is uncertain how much of the effect is due to protein. Vegetables and fruits might also be important in reducing CVD risk. 44 Thus, there is some evidence for a potential benefit on CVD risk and body weight of replacing carbohydrates with protein. However, long-term trials on weight loss and CVD outcome are lacking, and worries about safety of highprotein diets on bone and renal metabolism should be settled.
Although the evidence is still limited and insufficient to advise a large increase in protein intake, recommendations on protein could be more liberal. Not only animal protein sources, but in particular vegetable protein sources low in saturated fats, such as nuts, soy products and legumes should be considered.
Conclusions and implication
Reductions in dietary fat do not necessarily reduce obesity and overweight. Any effect on body weight will be related to the overall diet and the type of foods used, their energy density and acceptability for sustained lower energy intake. Success of weight loss seems mainly determined by compliance to energy restriction and less by the macronutrient composition of the diets.
High-unsaturated fat diets offer more benefits for reducing CVD risk than high-carbohydrate diets. Even if increasing unsaturated fatty acid intake at the expense of carbohydrates would produce some weight gain on the long-term, the net effect on CVD risk is probably beneficial.
Effects of the type of carbohydrate on CVD risk are much less clear than those of the type of fat, but it appears justified to advise limiting the intake of fructose, and increasing the intakes of whole-grain foods rich in fibre, and of vegetables and fruits. Increasing protein intake at the expense of carbohydrates could lower CVD risk and help to facilitate weight loss, but this and absence of adverse effects should be confirmed in long-term trials.
The current evidence indicates that a healthy diet can be moderately high in fat (30-40 en%), with saturated and trans fatty acids kept low and the remainder as a mixture of omega-9, omega-6 and omega-3 unsaturated fatty acids, contains carbohydrates preferably in the form of whole-grain foods, vegetables and fruits, and could be more liberal in protein intake. Extreme diets of any type should not be recommended. Finally, there is widespread consensus that dietary measures for a healthy body weight and reducing risk of CVD should always be accompanied by measures to increase physical activity.
